Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody
Abstract Background Distinct clinical presentations of interstitial lung disease (ILD) with the myositis-specific antibodies, including anti-synthetase antibodies, are well-recognized. However, the association between ILD and the myositis-associated antibodies, including anti-Ro52, is less establish...
Main Authors: | A. Sclafani, K. M. D’Silva, B. P. Little, E. M. Miloslavsky, J. J. Locascio, A. Sharma, S. B. Montesi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-019-1231-7 |
Similar Items
-
Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease
by: Sofia A. Moll, et al.
Published: (2020-09-01) -
Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
by: Adelle S. Jee, et al.
Published: (2017-05-01) -
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist–Pulmonologist Collaboration Is Essential
by: Marco Sebastiani, et al.
Published: (2021-12-01) -
Interstitial pneumonia with autoimmune features: A case series and overview
by: Ana Luísa Fernandes, et al.
Published: (2021-01-01) -
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3.6-Year Prospective Study from a Referral Center of Interstitial Lung Disease and Lung Transplantation
by: Belén Atienza-Mateo, et al.
Published: (2020-05-01)